mind medicine mindmed glp-1 receptor agonist medications Clinic Near Me in Fayetteville, NC The Power of Discovery: GLP-1

PlexusDx genetic insights, combined with comprehensive metabolic assessment, empower more informed shared decision-making around medication selection and realistic outcome expectations

Introduction Concerns about thyroid cancer with glucagon-like peptide 1 (GLP1) receptor agonist use were first raised in the premarketing phase after studies showed increased rates of thyroid C cell tumours in rodents.1 While the relevance of these findings to humans is not known, in the United States, product labels of GLP1 receptor agonists include boxed warnings about thyroid cancer and these drugs are contraindicated in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2

doi: 10.1136/bmjpo-2019-000624

Summary: Hair loss from GLP-1 medications is typically temporary telogen effluvium caused by rapid weight loss and nutritional changes, manageable through adequate protein intake, micronutrient optimisation, and moderating weight reduction rate

Most patients tolerate the medications well after the initial adjustment period

4 Gastroparesis, also known as stomach paralysis or delayed gastric emptying, is a condition in which undigested food stays in the stomach for prolonged periods of time and can cause severe nausea, vomiting and severe abdominal pain